Increased Licensing-In Activities by Domestic Firms

Published: 2005-03-04 06:57:00

Updated: 2005-03-04 06:57:00

A number of domestic pharmaceutical firms are undertaking the licensing-in activities to introduce competitive products in the domestic ethical medication market, and the industry expects that such introductions will help these companies realize higher sales.

Daewoong Pharmaceutical recently ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK